Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Selektiv nivåstrukturering av svensk kirurgi behövs.

Andersson R, Hellman P, Johansson J, Lagergren J, Martling A, Naredi P, Nilsson M, Sund M.

Lakartidningen. 2018 May 25;115. pii: E76E. Swedish. No abstract available.

PMID:
29809271
Free Article
2.

Diagnostic profile characteristics of cancer patients with frequent consultations in primary care before diagnosis: a case-control study.

Ewing M, Naredi P, Zhang C, Månsson J.

Fam Pract. 2018 Mar 13. doi: 10.1093/fampra/cmy012. [Epub ahead of print]

PMID:
29546418
3.

ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer.

Allum W, Lordick F, Alsina M, Andritsch E, Ba-Ssalamah A, Beishon M, Braga M, Caballero C, Carneiro F, Cassinello F, Dekker JW, Delgado-Bolton R, Haustermans K, Henning G, Hutter B, Lövey J, Netíková IŠ, Obermannová R, Oberst S, Rostoft S, Saarto T, Seufferlein T, Sheth S, Wynter-Blyth V, Costa A, Naredi P.

Crit Rev Oncol Hematol. 2018 Feb;122:179-193. doi: 10.1016/j.critrevonc.2017.12.019. Epub 2018 Jan 2. Review.

4.

ECCO essential requirements for quality cancer care: Melanoma.

Wouters MW, Michielin O, Bastiaannet E, Beishon M, Catalano O, Del Marmol V, Delgado-Bolton R, Dendale R, Trill MD, Ferrari A, Forsea AM, Kreckel H, Lövey J, Luyten G, Massi D, Mohr P, Oberst S, Pereira P, Prata JPP, Rutkowski P, Saarto T, Sheth S, Spurrier-Bernard G, Vuoristo MS, Costa A, Naredi P.

Crit Rev Oncol Hematol. 2018 Feb;122:164-178. doi: 10.1016/j.critrevonc.2017.12.020. Epub 2018 Jan 2. Review.

5.

Centers of excellence or excellence networks: The surgical challenge and quality issues in rare cancers.

Sandrucci S, Naredi P, Bonvalot S.

Eur J Surg Oncol. 2018 Jan 30. pii: S0748-7983(18)30107-0. doi: 10.1016/j.ejso.2017.12.012. [Epub ahead of print]

PMID:
29395437
6.

Future cancer research priorities in the USA: a Lancet Oncology Commission.

Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A.

Lancet Oncol. 2017 Nov;18(11):e653-e706. doi: 10.1016/S1470-2045(17)30698-8. Epub 2017 Oct 31. Review.

PMID:
29208398
7.

The European Cancer Patient's Bill of Rights, update and implementation 2016.

Højgaard L, Löwenberg B, Selby P, Lawler M, Banks I, Law K, Albreht T, Armand JP, Barbacid M, Barzach M, Bergh J, Cameron D, Conte P, de Braud F, de Gramont A, De Lorenzo F, Diehl V, Diler S, Erdem S, Geissler J, Gore-Booth J, Henning G, Horgan D, Jassem J, Johnson P, Kaasa S, Kapitein P, Karjalainen S, Kelly J, Kienesberger A, La Vecchia C, Lacombe D, Lindahl T, Luzzatto L, Malby R, Mastris K, Meunier F, Murphy M, Naredi P, Nurse P, Oliver K, Pearce J, Pelouchov J, Piccart M, Pinedo B, Spurrier-Bernard G, Sullivan R, Tabernero J, Van de Velde C, van Herk B, Vedsted P, Waldmann A, Weller D, Wilking N, Wilson R, Yared W, Zielinski C, Zur Hausen H, Le Chevalier T, Johnston P.

ESMO Open. 2017 Jan 6;1(6):e000127. doi: 10.1136/esmoopen-2016-000127. eCollection 2016. Review.

8.

Multidisciplinary training of cancer specialists in Europe.

Benstead K, Turhal NS, O'Higgins N, Wyld L, Czarnecka-Operacz M, Gollnick H, Naredi P, Eriksen JG.

Eur J Cancer. 2017 Sep;83:1-8. doi: 10.1016/j.ejca.2017.05.043. Epub 2017 Jul 10.

PMID:
28704643
9.

Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper.

Aapro M, Astier A, Audisio R, Banks I, Bedossa P, Brain E, Cameron D, Casali P, Chiti A, De Mattos-Arruda L, Kelly D, Lacombe D, Nilsson PJ, Piccart M, Poortmans P, Riklund K, Saeter G, Schrappe M, Soffietti R, Travado L, van Poppel H, Wait S, Naredi P.

Eur J Cancer. 2017 Sep;82:193-202. doi: 10.1016/j.ejca.2017.04.014. Epub 2017 Jul 7.

10.

ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review.

Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, Delgado Bolton R, Donati DM, Douis H, Haas R, Hogendoorn P, Kozhaeva O, Lavender V, Lovey J, Negrouk A, Pereira P, Roca P, de Lempdes GR, Saarto T, van Berck B, Vassal G, Wartenberg M, Yared W, Costa A, Naredi P.

Crit Rev Oncol Hematol. 2017 Feb;110:94-105. doi: 10.1016/j.critrevonc.2016.12.002. Epub 2016 Dec 8. Review.

11.

ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review.

Beets G, Sebag-Montefiore D, Andritsch E, Arnold D, Beishon M, Crul M, Dekker JW, Delgado Bolton R, Fléjou JF, Grisold W, Henning G, Laghi A, Lovey J, Negrouk A, Pereira P, Roca P, Saarto T, Seufferlein T, Taylor C, Ugolini G, Velde CV, Herck BV, Yared W, Costa A, Naredi P.

Crit Rev Oncol Hematol. 2017 Feb;110:81-93. doi: 10.1016/j.critrevonc.2016.12.001. Epub 2016 Dec 8. Review.

12.

Identification of patients with non-metastatic colorectal cancer in primary care: a case-control study.

Ewing M, Naredi P, Zhang C, Månsson J.

Br J Gen Pract. 2016 Dec;66(653):e880-e886. Epub 2016 Nov 7.

13.

Increased consultation frequency in primary care, a risk marker for cancer: a case-control study.

Ewing M, Naredi P, Nemes S, Zhang C, Månsson J.

Scand J Prim Health Care. 2016 Jun;34(2):205-12. doi: 10.1080/02813432.2016.1183692. Epub 2016 May 18.

14.

Present and future role of surgery in metastatic gastrointestinal malignancies.

Naredi P, Olofsson Bagge R.

Curr Opin Oncol. 2016 Jul;28(4):348-52. doi: 10.1097/CCO.0000000000000297. Review.

PMID:
27136137
15.

Alterations in Tumor DNA Are Related to Short Postoperative Survival in Patients Resected for Pancreatic Carcinoma Aimed at Cure.

Asting AG, Ljungman D, Carén H, Dambrauskas Z, Iresjö BM, Hyltander A, Naredi P, Lundholm K.

Pancreas. 2016 Jul;45(6):900-7. doi: 10.1097/MPA.0000000000000566.

PMID:
26684859
16.

Asna1/TRC40 Controls β-Cell Function and Endoplasmic Reticulum Homeostasis by Ensuring Retrograde Transport.

Norlin S, Parekh VS, Naredi P, Edlund H.

Diabetes. 2016 Jan;65(1):110-9. doi: 10.2337/db15-0699. Epub 2015 Oct 5.

17.

Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.

Nyström H, Tavelin B, Björklund M, Naredi P, Sund M.

Tumour Biol. 2015 Dec;36(12):9839-47. doi: 10.1007/s13277-015-3729-z. Epub 2015 Jul 11.

18.

Circulating carnosine dipeptidase 1 associates with weight loss and poor prognosis in gastrointestinal cancer.

Arner P, Henjes F, Schwenk JM, Darmanis S, Dahlman I, Iresjö BM, Naredi P, Agustsson T, Lundholm K, Nilsson P, Rydén M.

PLoS One. 2015 Apr 21;10(4):e0123566. doi: 10.1371/journal.pone.0123566. eCollection 2015.

19.

The future of trials in surgical oncology.

Naredi P, La Quaglia MP.

Nat Rev Clin Oncol. 2015 Jul;12(7):425-31. doi: 10.1038/nrclinonc.2015.72. Epub 2015 Apr 14. Review.

PMID:
25869462
20.

Protection against cold in prehospital care: wet clothing removal or addition of a vapor barrier.

Henriksson O, Lundgren PJ, Kuklane K, Holmér I, Giesbrecht GG, Naredi P, Bjornstig U.

Wilderness Environ Med. 2015 Mar;26(1):11-20. doi: 10.1016/j.wem.2014.07.001.

PMID:
25712295
21.

Combining conventional and stroma-derived tumour markers in pancreatic ductal adenocarcinoma.

Franklin O, Öhlund D, Lundin C, Öman M, Naredi P, Wang W, Sund M.

Cancer Biomark. 2015;15(1):1-10. doi: 10.3233/CBM-140430.

PMID:
25524936
22.

Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.

Lyth J, Eriksson H, Hansson J, Ingvar C, Jansson M, Lapins J, Månsson-Brahme E, Naredi P, Stierner U, Ullenhag G, Carstensen J, Lindholm C.

Br J Dermatol. 2015 Mar;172(3):700-6. doi: 10.1111/bjd.13483. Epub 2015 Feb 5.

23.

Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions.

Einarsdottir BO, Bagge RO, Bhadury J, Jespersen H, Mattsson J, Nilsson LM, Truvé K, López MD, Naredi P, Nilsson O, Stierner U, Ny L, Nilsson JA.

Oncotarget. 2014 Oct 30;5(20):9609-18.

24.

Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.

Eriksson H, Lyth J, Månsson-Brahme E, Frohm-Nilsson M, Ingvar C, Lindholm C, Naredi P, Stierner U, Carstensen J, Hansson J.

J Clin Oncol. 2014 May 1;32(13):1356-64. doi: 10.1200/JCO.2013.52.7564. Epub 2014 Mar 31. Erratum in: J Clin Oncol. 2014 Dec 10;32(35):4025.

PMID:
24687828
25.

Validity and reliability of the Cold Discomfort Scale: a subjective judgement scale for the assessment of patient thermal state in a cold environment.

Lundgren P, Henriksson O, Kuklane K, Holmér I, Naredi P, Björnstig U.

J Clin Monit Comput. 2014 Jun;28(3):287-91. doi: 10.1007/s10877-013-9533-7. Epub 2013 Dec 6.

26.

Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012: science, opinions and experiences from the experts of surgery.

van de Velde CJ, Boelens PG, Tanis PJ, Espin E, Mroczkowski P, Naredi P, Pahlman L, Ortiz H, Rutten HJ, Breugom AJ, Smith JJ, Wibe A, Wiggers T, Valentini V.

Eur J Surg Oncol. 2014 Apr;40(4):454-68. doi: 10.1016/j.ejso.2013.10.013. Epub 2013 Nov 8. Review.

PMID:
24268926
27.

EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.

van de Velde CJ, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, Beets-Tan RG, van den Broek CB, Brown G, Van Cutsem E, Espin E, Haustermans K, Glimelius B, Iversen LH, van Krieken JH, Marijnen CA, Henning G, Gore-Booth J, Meldolesi E, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten H, Schmoll HJ, Smith JJ, Tanis PJ, Taylor C, Wibe A, Wiggers T, Gambacorta MA, Aristei C, Valentini V.

Eur J Cancer. 2014 Jan;50(1):1.e1-1.e34. doi: 10.1016/j.ejca.2013.06.048. Epub 2013 Oct 31.

PMID:
24183379
28.

Expression of major histocompatibility complex class I-related chain A/B (MICA/B) in pancreatic carcinoma.

Dambrauskas Z, Svensson H, Joshi M, Hyltander A, Naredi P, Iresjö BM.

Int J Oncol. 2014 Jan;44(1):99-104. doi: 10.3892/ijo.2013.2156. Epub 2013 Oct 31.

PMID:
24173243
29.

Depletion of the ER chaperone ENPL-1 sensitizes C. elegans to the anticancer drug cisplatin.

Natarajan B, Gaur R, Hemmingsson O, Kao G, Naredi P.

Worm. 2013 Jan 1;2(1):e24059. doi: 10.4161/worm.24059.

30.

Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.

Palm-Espling ME, Lundin C, Björn E, Naredi P, Wittung-Stafshede P.

Protein Pept Lett. 2014;21(1):63-8.

PMID:
23988033
31.

EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe.

van de Velde CJ, Aristei C, Boelens PG, Beets-Tan RG, Blomqvist L, Borras JM, van den Broek CB, Brown G, Coebergh JW, Cutsem EV, Espin E, Gore-Booth J, Glimelius B, Haustermans K, Henning G, Iversen LH, Han van Krieken J, Marijnen CA, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten HJ, Schmoll HJ, Smith J, Tanis PJ, Taylor C, Wibe A, Gambacorta MA, Meldolesi E, Wiggers T, Cervantes A, Valentini V; European Registration of Cancer Care.

Eur J Cancer. 2013 Sep;49(13):2784-90. doi: 10.1016/j.ejca.2013.04.032. Epub 2013 Jun 14.

PMID:
23769991
32.

Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.

Eriksson H, Lyth J, Månsson-Brahme E, Frohm-Nilsson M, Ingvar C, Lindholm C, Naredi P, Stierner U, Wagenius G, Carstensen J, Hansson J.

Eur J Cancer. 2013 Aug;49(12):2705-16. doi: 10.1016/j.ejca.2013.03.013. Epub 2013 Apr 11.

PMID:
23583439
33.

Liver-metastatic potential of colorectal cancer is related to the stromal composition of the tumour.

Nyström H, Naredi P, Berglund A, Palmqvist R, Tavelin B, Sund M.

Anticancer Res. 2012 Dec;32(12):5183-91.

PMID:
23225415
34.

Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.

Lyth J, Hansson J, Ingvar C, Månsson-Brahme E, Naredi P, Stierner U, Wagenius G, Lindholm C; Swedish Melanoma Study Group.

Br J Dermatol. 2013 Apr;168(4):779-86. doi: 10.1111/bjd.12095. Epub 2013 Jan 18.

35.

Non-invasive identification of melanoma with near-infrared and skin impedance spectroscopy.

Bodén I, Nyström J, Lundskog B, Zazo V, Geladi P, Lindholm-Sethson B, Naredi P.

Skin Res Technol. 2013 Feb;19(1):e473-8. doi: 10.1111/j.1600-0846.2012.00668.x. Epub 2012 Sep 7.

PMID:
22958059
36.

A directed RNAi screen based on larval growth arrest reveals new modifiers of C. elegans insulin signaling.

Billing O, Natarajan B, Mohammed A, Naredi P, Kao G.

PLoS One. 2012;7(4):e34507. doi: 10.1371/journal.pone.0034507. Epub 2012 Apr 12.

37.

Protection against cold in prehospital care: evaporative heat loss reduction by wet clothing removal or the addition of a vapor barrier--a thermal manikin study.

Henriksson O, Lundgren P, Kuklane K, Holmér I, Naredi P, Bjornstig U.

Prehosp Disaster Med. 2012 Feb;27(1):53-8. doi: 10.1017/S1049023X12000210. Epub 2012 Mar 23.

PMID:
22445055
38.

NIR and skin impedance spectroscopic measurements for studying the effect of coffee and alcohol on skin, and dysplastic naevi.

Bodén I, Nyström J, Geladi P, Naredi P, Lindholm-Sethson B.

Skin Res Technol. 2012 Nov;18(4):486-94. doi: 10.1111/j.1600-0846.2011.00597.x. Epub 2011 Dec 18.

PMID:
22175794
39.

Better value cancer care for the 21st century.

Gray M, Naredi P, Bacon N, Kerr DJ.

Ann Oncol. 2011 Dec;22(12):2541-5. doi: 10.1093/annonc/mdr457. Epub 2011 Nov 2. No abstract available.

PMID:
22052989
40.

The effect of active warming in prehospital trauma care during road and air ambulance transportation - a clinical randomized trial.

Lundgren P, Henriksson O, Naredi P, Björnstig U.

Scand J Trauma Resusc Emerg Med. 2011 Oct 21;19:59. doi: 10.1186/1757-7241-19-59.

41.

Delivering affordable cancer care in high-income countries.

Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T, Siderov J, Williamson S, Camporesi S, McVie JG, Purushotham AD, Naredi P, Eggermont A, Brennan MF, Steinberg ML, De Ridder M, McCloskey SA, Verellen D, Roberts T, Storme G, Hicks RJ, Ell PJ, Hirsch BR, Carbone DP, Schulman KA, Catchpole P, Taylor D, Geissler J, Brinker NG, Meltzer D, Kerr D, Aapro M.

Lancet Oncol. 2011 Sep;12(10):933-80. doi: 10.1016/S1470-2045(11)70141-3.

PMID:
21958503
42.

Type IV collagen as a tumour marker for colorectal liver metastases.

Nyström H, Naredi P, Hafström L, Sund M.

Eur J Surg Oncol. 2011 Jul;37(7):611-7. doi: 10.1016/j.ejso.2011.04.010. Epub 2011 May 28.

PMID:
21620632
43.

In vivo skin measurements with a novel probe head for simultaneous skin impedance and near-infrared spectroscopy.

Bodén I, Larsson W, Nilsson D, Forssell E, Naredi P, Lindholm-Sethson B.

Skin Res Technol. 2011 Nov;17(4):494-504. doi: 10.1111/j.1600-0846.2011.00524.x. Epub 2011 Apr 15.

PMID:
21492242
44.

Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.

Palm ME, Weise CF, Lundin C, Wingsle G, Nygren Y, Björn E, Naredi P, Wolf-Watz M, Wittung-Stafshede P.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6951-6. doi: 10.1073/pnas.1012899108. Epub 2011 Apr 11.

45.

Mitochondrial function is required for secretion of DAF-28/insulin in C. elegans.

Billing O, Kao G, Naredi P.

PLoS One. 2011 Jan 17;6(1):e14507. doi: 10.1371/journal.pone.0014507.

46.

ASNA-1 activity modulates sensitivity to cisplatin.

Hemmingsson O, Kao G, Still M, Naredi P.

Cancer Res. 2010 Dec 15;70(24):10321-8. doi: 10.1158/0008-5472.CAN-10-1548. Epub 2010 Oct 21.

47.

Evaluation of cell lysis methods for platinum metallomic studies of human malignant cells.

Tran MQ, Nygren Y, Lundin C, Naredi P, Björn E.

Anal Biochem. 2010 Jan 1;396(1):76-82. doi: 10.1016/j.ab.2009.08.044. Epub 2009 Sep 3.

PMID:
19733145
48.

Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1.

Hemmingsson O, Nöjd M, Kao G, Naredi P.

Oncol Rep. 2009 Oct;22(4):869-75.

PMID:
19724867
49.

Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer.

Ohlund D, Lundin C, Ardnor B, Oman M, Naredi P, Sund M.

Br J Cancer. 2009 Jul 7;101(1):91-7. doi: 10.1038/sj.bjc.6605107. Epub 2009 Jun 2.

50.

Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005.

Mattsson J, Bergkvist L, Abdiu A, Aili Low JF, Naredi P, Ullberg K, Garpered U, Håkansson A, Ingvar C.

Acta Oncol. 2008;47(8):1519-25. doi: 10.1080/02841860701785533.

PMID:
18941953

Supplemental Content

Loading ...
Support Center